# S&T Bancorp Inc: financial statements, quarterly

STBA · Nasdaq · CIK 719220 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stba.md) · [Financials](/companies/stba/financials.md) · [Filings](/companies/stba/filings.md) · [Insiders](/companies/stba/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/stba/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [35.6](/filings/0000719220-23-000078.md) | [41.6 d](/filings/0000719220-24-000025.md) | [44.3](/filings/0000719220-24-000037.md) | [45.2](/filings/0000719220-24-000073.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.8](/filings/0000719220-24-000091.md) | [9.0 d](/filings/0000719220-26-000030.md) | [7.9](/filings/0000719220-25-000028.md) | [8.5](/filings/0000719220-25-000053.md) | [8.9](/filings/0000719220-25-000091.md) | [8.3 d](/filings/0000719220-26-000030.md) | [8.3](/filings/0000719220-26-000050.md) | [8.1](/filings/0000719220-26-000098.md) | [8.9](/filings/0000719220-25-000091.md) | [8.5 d](/filings/0000719220-26-000030.md) | [9.0](/filings/0000719220-26-000050.md) | [8.8](/filings/0000719220-26-000098.md) |
| Net income | $m | [33.5](/filings/0000719220-24-000091.md) | [37.0 d](/filings/0000719220-26-000030.md) | [31.2](/filings/0000719220-25-000028.md) | [34.4](/filings/0000719220-25-000053.md) | [32.6](/filings/0000719220-25-000091.md) | [33.1 d](/filings/0000719220-26-000030.md) | [33.4](/filings/0000719220-26-000050.md) | [31.9](/filings/0000719220-26-000098.md) | [35.0](/filings/0000719220-25-000091.md) | [34.0 d](/filings/0000719220-26-000030.md) | [35.1](/filings/0000719220-26-000050.md) | [36.6](/filings/0000719220-26-000098.md) |
| Diluted EPS | $ per share | [0.87](/filings/0000719220-24-000091.md) | not reported | [0.81](/filings/0000719220-25-000028.md) | [0.89](/filings/0000719220-25-000053.md) | [0.85](/filings/0000719220-25-000091.md) | not reported | [0.87](/filings/0000719220-26-000050.md) | [0.83](/filings/0000719220-26-000098.md) | [0.91](/filings/0000719220-25-000091.md) | not reported | [0.94](/filings/0000719220-26-000050.md) | [1.02](/filings/0000719220-26-000098.md) |
| Basic EPS | $ per share | [0.88](/filings/0000719220-24-000091.md) | not reported | [0.82](/filings/0000719220-25-000028.md) | [0.90](/filings/0000719220-25-000053.md) | [0.85](/filings/0000719220-25-000091.md) | not reported | [0.87](/filings/0000719220-26-000050.md) | [0.83](/filings/0000719220-26-000098.md) | [0.91](/filings/0000719220-25-000091.md) | not reported | [0.95](/filings/0000719220-26-000050.md) | [1.03](/filings/0000719220-26-000098.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [238](/filings/0000719220-23-000078.md) | [234](/filings/0000719220-25-000013.md) | [207](/filings/0000719220-24-000037.md) | [246](/filings/0000719220-24-000073.md) | [228](/filings/0000719220-24-000091.md) | [245](/filings/0000719220-26-000030.md) | [212](/filings/0000719220-25-000028.md) | [203](/filings/0000719220-25-000053.md) | [196](/filings/0000719220-25-000091.md) | [163](/filings/0000719220-26-000098.md) | [339](/filings/0000719220-26-000050.md) | [218](/filings/0000719220-26-000098.md) |
| Total assets | $m | [9,466](/filings/0000719220-23-000078.md) | [9,552](/filings/0000719220-25-000013.md) | [9,539](/filings/0000719220-24-000037.md) | [9,635](/filings/0000719220-24-000073.md) | [9,584](/filings/0000719220-24-000091.md) | [9,658](/filings/0000719220-26-000030.md) | [9,718](/filings/0000719220-25-000028.md) | [9,810](/filings/0000719220-25-000053.md) | [9,817](/filings/0000719220-25-000091.md) | [9,871](/filings/0000719220-26-000098.md) | [9,944](/filings/0000719220-26-000050.md) | [9,944](/filings/0000719220-26-000098.md) |
| Total liabilities | $m | [8,243](/filings/0000719220-23-000078.md) | [8,268](/filings/0000719220-25-000013.md) | [8,244](/filings/0000719220-24-000037.md) | [8,314](/filings/0000719220-24-000073.md) | [8,208](/filings/0000719220-24-000091.md) | [8,278](/filings/0000719220-26-000030.md) | [8,300](/filings/0000719220-25-000028.md) | [8,365](/filings/0000719220-25-000053.md) | [8,342](/filings/0000719220-25-000091.md) | [8,407](/filings/0000719220-26-000098.md) | [8,513](/filings/0000719220-26-000050.md) | [8,540](/filings/0000719220-26-000098.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [415](/filings/0000719220-26-000030.md) | not reported | not reported | not reported | [150](/filings/0000719220-26-000030.md) | not reported | not reported | not reported | [165](/filings/0000719220-26-000030.md) | not reported | not reported |
| Shareholders' equity | $m | [1,224](/filings/0000719220-24-000091.md) | [1,283](/filings/0000719220-26-000030.md) | [1,295](/filings/0000719220-25-000053.md) | [1,321](/filings/0000719220-25-000091.md) | [1,376](/filings/0000719220-25-000091.md) | [1,380](/filings/0000719220-26-000098.md) | [1,418](/filings/0000719220-26-000098.md) | [1,445](/filings/0000719220-26-000098.md) | [1,475](/filings/0000719220-25-000091.md) | [1,464](/filings/0000719220-26-000098.md) | [1,431](/filings/0000719220-26-000098.md) | [1,404](/filings/0000719220-26-000098.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [57.8 d](/filings/0000719220-24-000091.md) | [30.9 d](/filings/0000719220-26-000030.md) | [46.4](/filings/0000719220-25-000028.md) | [44.7 d](/filings/0000719220-25-000053.md) | [27.6 d](/filings/0000719220-25-000091.md) | [54.6 d](/filings/0000719220-26-000030.md) | [28.9](/filings/0000719220-26-000050.md) | [28.3 d](/filings/0000719220-26-000098.md) | [40.3 d](/filings/0000719220-25-000091.md) | [36.2 d](/filings/0000719220-26-000030.md) | [42.5](/filings/0000719220-26-000050.md) | [27.8 d](/filings/0000719220-26-000098.md) |
| Capital expenditure | $m | [2.2 d](/filings/0000719220-24-000091.md) | [0.6 d](/filings/0000719220-26-000030.md) | [0.5](/filings/0000719220-25-000028.md) | [0.8 d](/filings/0000719220-25-000053.md) | [0.7 d](/filings/0000719220-25-000091.md) | [0.9 d](/filings/0000719220-26-000030.md) | [1.7](/filings/0000719220-26-000050.md) | [1.2 d](/filings/0000719220-26-000098.md) | [0.6 d](/filings/0000719220-25-000091.md) | [1.2 d](/filings/0000719220-26-000030.md) | [1.0](/filings/0000719220-26-000050.md) | [0.8 d](/filings/0000719220-26-000098.md) |
| Dividends paid | $m | [12.3 d](/filings/0000719220-24-000091.md) | [12.6 d](/filings/0000719220-26-000030.md) | [12.6](/filings/0000719220-25-000028.md) | [12.7 d](/filings/0000719220-25-000053.md) | [12.6 d](/filings/0000719220-25-000091.md) | [13.0 d](/filings/0000719220-26-000030.md) | [13.0](/filings/0000719220-26-000050.md) | [13.2 d](/filings/0000719220-26-000098.md) | [13.1 d](/filings/0000719220-25-000091.md) | [13.6 d](/filings/0000719220-26-000030.md) | [13.4](/filings/0000719220-26-000050.md) | [13.3 d](/filings/0000719220-26-000098.md) |
| Share repurchases | $m | [0.0 d](/filings/0000719220-24-000091.md) | [0.0 d](/filings/0000719220-26-000030.md) | not reported | not reported | [0.0 d](/filings/0000719220-24-000091.md) | [0.0 d](/filings/0000719220-26-000030.md) | [0.0](/filings/0000719220-26-000050.md) | [0.0 d](/filings/0000719220-26-000098.md) | not reported | not reported | [49.7](/filings/0000719220-26-000050.md) | [47.6 d](/filings/0000719220-26-000098.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.2](/filings/0000719220-23-000058.md) | [39.0](/filings/0000719220-24-000037.md) | [38.6](/filings/0000719220-24-000073.md) | [38.4](/filings/0000719220-24-000091.md) | [38.4](/filings/0000719220-25-000028.md) | [38.5](/filings/0000719220-25-000053.md) | [38.6](/filings/0000719220-25-000091.md) | [38.6](/filings/0000719220-26-000050.md) | [38.6](/filings/0000719220-26-000098.md) | [38.6](/filings/0000719220-25-000091.md) | [37.2](/filings/0000719220-26-000050.md) | [36.0](/filings/0000719220-26-000098.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 35,265,492 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0000719220-26-000098.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.